Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

      ( print page 14574)    
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Regulation of Cytokine Transcription and Inflammation.                    

*Date:*                         March 30, 2009.                    

*Time:*                         1 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).                    

*Contact Person:*                         Jay Bruce Sundstrom, PhD, Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 3119, 6700B Rockledge Drvie, MSC-7616, Bethesda, MD 20892-7616, 301-496-7042,                         *sundstromj@niaid.nih.gov.*

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; B Cell Epitope Discovery and Mechanisms of Antibody Protection.                    

*Date:*                         April 20-21, 2009.                    

*Time:*                         8 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         The Legacy Hotel and Meeting Centre, 1775 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Quirijn Vos, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIH/NIAID/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301-451-2666,                         *qvos@niaid.nih.gov.*

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Rapid HIV Point-of-Care Diagnostic Device for Resource-Limited Setting.                    

*Date:*                         April 20-21, 2009.                    

*Time:*                         8 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         Doubletree Hotel and Executive Meeting Center, 8120 Wisconsin Ave, Bethesda, MD 20814.                    

*Contact Person:*                         Roberta Binder, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Room 3130, Bethesda, MD 20892-7616, 301-496-7966,                         *rbinder@niaid.nih.gov.*

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Ancillary Studies in Immunomodulation Clinical Trials.                    

*Date:*                         April 24, 2009.                    

*Time:*                         2 p.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).                    

*Contact Person:*                         Paul A. Amstad, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, 301-402-7098,                         *pamstad@niaid.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: March 25, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

 [FR Doc. E9-7197 Filed 3-30-09; 8:45 am]

BILLING CODE 4140-01-P